AJEM, the first and only American medical authority committed to scientific study of the ECS, and to the evidence-based practice of Endocannabinoid Medicine.
The objective of the American Journal of Endocannabinoid Medicine is to help educate medical professionals on the role of the endocannabinoid system in homeostasis, and as a therapeutic target for cannabis and cannabinoid prescription and non-prescription products.
AJEM aims to present/ interpret the currently available authoritative research, while stimulating questions regarding the role of medical cannabis in all forms, as a growing methodology in the field of treatment and patient care. The intent of AJEM is to be utilized as a clinical resource and contribute to the examination and overall scientific discussion of the endocannabinoid system.
The American Journal of Endocannabinoid Medicine is an official journal of the ACS. To learn more about the benefits of membership in the ACS, click here.